Email a Friend
Print ArticleHealthy Aging Health Center
News Related to Healthy Seniors
-
Older People Get Brain Boost From Internet
Oct. 19, 2009 -- Surfing the Internet may be the latest way to teach an old dog new tricks. A study shows older adults who learn to use the Internet to search for information experience a surge of activity in key decision-making and reasoning centers of the brain. "We found that for older people wit
Read Full Article -
Stay Healthy in Retirement With Work
Oct. 16, 2009 -- People who continue to work after retirement have fewer diseases and fewer functional limitations than people who quit completely, a study shows. The study shows that "bridge employment" -- which researchers define as a part-time job or self-employment -- is in general good for heal
Read Full Article -
Hip Fractures on the Decline in U.S.
Oct. 12, 2009 -- Hip fracture rates and deaths related to such injuries are decreasing in the U.S. among people aged 65 and older, a new study shows. Scientists reporting in the Oct. 14 issue of The Journal of the American Medical Association say the reasons for the declining fracture and death rate
Read Full Article -
Vermont Tops List of Best Health Systems
Oct. 8, 2009 -- As the debate over health reform rages on, Vermonters can rejoice: Their state has the best-performing health system in the nation. Meanwhile, states across the South and West are still struggling with high rates of uninsured residents, poor quality of health care, and wasteful spend
Read Full Article -
Convertibles Hazardous to Your Hearing?
Oct. 6, 2009 -- Convertible lovers who take to the open road with the top down may be risking hearing damage, according to a new study out of the U.K. "If you are exposed for long periods above 85 decibels [of sound], you have the potential for hearing loss," says Philip Michael, MD, an ear-nose-thr
Read Full Article -
Vitamin D May Help Prevent Falls
Oct. 2, 2009 -- Taking vitamin D supplements, at a dose of 700-1,000 international units per day, may make falling 19% less likely for people aged 65 and older. That news comes from a research review published online in BMJ, formerly called the British Medical Journal. The review is based on eight s
Read Full Article -
Study: ER Patients Wait Too Long for Care
Oct. 2, 2009 -- Even the sickest patients treated in hospital emergency departments across the U.S. routinely wait longer than they should for medical care, new research suggests. Just 14% of hospitals met their own target time frame for treating very sick patients at least 90% of the time. And slig
Read Full Article -
Living to 100 to Become Common?
Oct. 1, 2009 -- Reaching the age of 100 may become pretty ordinary for most babies born in rich countries since 2000, according to a new report. "If the pace of increase in life expectancy in developed countries over the past two centuries continues through the 21st century, most babies born since 2
Read Full Article -
Health Care Costs Rise Again for Workers, Firms
Sept. 15, 2009 -- The cost of job-based health insurance continued to take a bigger bite from workers and employers this year, rising 5% for family coverage. This increase in total premiums, moderate by recent historical trends, outstripped the 0.7% drop in general inflation and an average 3.1% hik
Read Full Article -
More Americans Have No Health Insurance
Sept. 10, 2009 -- The number of Americans without health insurance rose slightly to 46.3 million in 2008, as enrollment growth in safety-net programs helped counter the continued slippage in job-based coverage. The annual Census Bureau report, released Thursday, shows that an additional 680,000 peop
Read Full Article
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Please see UROXATRAL full prescribing information.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.
